Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875339 · ClinicalTrials.gov registry record · NA
Communities Helping the Hearing of Infants by Reaching Parents
A NA study, sponsored by Matthew Bush, MD.
- Completed
- Registry status
- NA
- Development phase
- 2,699
- Enrollment target
NCT03875339: Completed NA study, sponsored by Matthew Bush, MD.
NCT03875339 is a NA study that has completed, run by Matthew Bush, MD. The registered enrollment target is 2,699 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03875339, a NA study, has completed, sponsored by Matthew Bush, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,699 participants
- Enrollment target
Study Summary
Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children. The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.
Primary Outcome
This outcome is the number of participants who do not follow-up at an OCSHCN Clinic for diagnostic audiologic testing after a failed newborn hearing screening from the date of randomization to 3 months after birth.
Interventions
- BEHAVIORAL Navigator Guidance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,699 participants |
| Start Date | 2021-01-13 |
| Est. Completion | 2023-09-08 |
| Phase | NA |
What the finished NCT03875339 record still lists
NCT03875339 is an interventional study that assigns participants to a tested intervention. Its 2,699 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% higher).
The record links to 0 conditions, and to 1 intervention - of which Navigator Guidance is the first listed.
NCT03875339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03875339 about?
NCT03875339 is a clinical study titled "Communities Helping the Hearing of Infants by Reaching Parents". Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed tes...
What is the current status of trial NCT03875339?
This trial is currently completed. It is a NA study. The enrollment target is 2,699 participants. The study started on 2021-01-13. Estimated completion is 2023-09-08.
What interventions are being tested in trial NCT03875339?
The interventions under investigation include: Navigator Guidance (BEHAVIORAL).
Who is sponsoring clinical trial NCT03875339?
This trial is sponsored by Matthew Bush, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03875339's enrollment target sits among peer trials
2,699 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05125939 · 2,700 participants
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI